A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine

PHASE3CompletedINTERVENTIONAL

Enrollment

211

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

December 31, 2001

Conditions

Vascular HeadachesMigraine

Interventions

DRUG

topiramate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00253175 - A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine | Biotech Hunter | Biotech Hunter